HUNTER SYNDROME (MPS II)

Clinical trials for HUNTER SYNDROME (MPS II) explained in plain language.

Never miss a new study

Get alerted when new HUNTER SYNDROME (MPS II) trials appear

Sign up with your email to follow new studies for HUNTER SYNDROME (MPS II), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

One-Shot gene therapy aims to halt devastating brain disease in toddlers

Disease control Terminated

This study is testing a one-time gene therapy called RGX-121 for young boys with a severe form of Hunter syndrome that affects the brain. The goal is to see if delivering a working gene directly to the brain can slow or stop the loss of thinking and developmental skills. The stud…

Matched conditions: HUNTER SYNDROME (MPS II)

Phase: PHASE3 • Sponsor: REGENXBIO Inc. • Aim: Disease control

Last updated Mar 05, 2026 14:00 UTC

HUNTER SYNDROME (MPS II)

Get alerted when new HUNTER SYNDROME (MPS II) trials appear

One-Shot gene therapy aims to halt devastating brain disease in toddlers